Nu Skin Enterprises, Inc. (NUS)
$3.80
+0.03 (+0.80%)Delayed quote.
Price history
Daily close- Start
- $10.00
- Latest close
- $3.80
- Period change
- -62.00%
- Period low
- $3.77
- Period high
- $11.54
Key metrics
- Market cap
- $184.98M
- Volume
- 794.1K
- Average volume
- 546.7K
- 52-week range
- $3.75 – $11.67
- Beta
- 0.93
- Last dividend
- $0.24
- EPS (TTM)
- -$4.82
- P/E ratio
- 2.96
- Revenue (TTM)
- $1.32B
- Net income (TTM)
- -$234.21M
- Total assets
- $1.09B
- Total debt
- $252.42M
- Cash and equivalents
- $164.90M
Key financials (trailing twelve months).
Company profile
Nu Skin Enterprises, Inc. (NUS) is a global enterprise dedicated to the creation and worldwide distribution of beauty and wellness solutions. The company's diverse product offerings encompass advanced skincare systems, such as the ageLOC Spa and ageLOC Transformation age-defying lines, innovative devices like the ageLOC LumiSpa for comprehensive skin treatment and cleansing, and the ageLOC Boost, alongside various other cosmetic and personal care items. In the realm of health and nutrition, Nu Skin provides a comprehensive array of dietary and weight management products. This includes ageLOC Youth, LifePak, and ageLOC Meta nutritional supplements, in addition to ageLOC TR90 programs designed for weight control and body contouring, Beauty Focus Collagen+ skin care supplements, and other related weight management aids. The organization also significantly invests in research and development, particularly for its skincare and nutritional supplement portfolios. Nu Skin operates a network of retail stores and customer service centers exclusively within Mainland China. Its extensive product lines are marketed under its proprietary brands, which include Nu Skin, Pharmanex, and ageLOC. These products reach consumers through multiple sales channels, including direct-to-consumer interactions, an extensive network of independent distributors, and its dedicated e-commerce platform. Nu Skin Enterprises, Inc. was established in 1984 and maintains its corporate headquarters in Provo, Utah.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Exchange
- NYSE
- CEO
- Ryan S. Napierski
- Employees
- 2,800
- Headquarters
- Provo, UT, US
- IPO date
- 1996-11-22
- Website
- https://www.nuskin.com
Financial statements
Annual, last 3 fiscal years. Most recent period first. Reported in USD.
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B |
| Gross profit | $1.03B | $1.18B | $1.36B |
| Operating income | $90.88M | -$151.59M | $48.27M |
| EBITDA | $262.41M | -$78.83M | $204.68M |
| Net income | $160.20M | -$146.59M | $8.60M |
| Diluted EPS | $3.18 | -$2.95 | $0.17 |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Cash and equivalents | $238.63M | $186.88M | $256.06M |
| Total assets | $1.41B | $1.47B | $1.81B |
| Total liabilities | $600.07M | $817.46M | $984.50M |
| Total debt | $364.25M | $478.23M | $607.33M |
| Shareholders’ equity | $805.24M | $651.46M | $821.97M |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Operating cash flow | $80.29M | $111.74M | $118.64M |
| Capital expenditure | -$34.28M | -$41.58M | -$58.49M |
| Free cash flow | $46.01M | $70.16M | $60.15M |
Quarterly, last 6 quarters. Most recent period first. Reported in USD.
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Revenue | $311.01M | $320.11M | $320.61M | $370.32M | $364.21M | $386.14M |
| Gross profit | $202.17M | $218.32M | $214.46M | $261.98M | $256.72M | $265.73M |
| Operating income | $5.09M | -$59.32M | $5.87M | $23.24M | $21.64M | $30.78M |
| EBITDA | $24.20M | -$47.20M | $19.19M | $35.10M | $32.23M | $42.99M |
| Net income | -$742.0K | -$249.80M | $1.84M | $14.49M | $17.08M | $21.12M |
| Diluted EPS | -$0.02 | -$5.14 | $0.04 | $0.29 | $0.34 | $0.43 |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $164.90M | $189.64M | $198.65M | $238.63M | $251.79M | $264.16M |
| Total assets | $1.09B | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B |
| Total liabilities | $540.60M | $578.79M | $582.71M | $600.07M | $624.61M | $655.94M |
| Total debt | $252.42M | $263.74M | $277.61M | $364.25M | $291.43M | $310.74M |
| Shareholders’ equity | $547.48M | $542.74M | $794.09M | $805.24M | $799.79M | $787.75M |
| Metric | Q3 2026Sep 30, 2026 | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$8.12M | $10.62M | -$3.92M | $16.62M | $27.48M | $35.80M |
| Capital expenditure | -$11.35M | -$5.64M | -$13.71M | -$10.76M | -$9.91M | -$18.0K |
| Free cash flow | -$19.47M | $4.99M | -$17.63M | $5.86M | $17.57M | $35.78M |